Truist Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Sell
189,953
-42,008
-18% -$3.36M 0.02% 561
2025
Q4
$22.1M Sell
231,961
-10,118
-4% -$992K 0.03% 384
2025
Q3
$23.6M Buy
242,079
+12,516
+5% +$1.3M 0.03% 372
2025
Q2
$24.7M Sell
229,563
-18,116
-7% -$1.83M 0.04% 348
2025
Q1
$25M Buy
247,679
+31,785
+15% +$3.2M 0.04% 334
2024
Q4
$19.3M Sell
215,894
-4,801
-2% -$423K 0.03% 398
2024
Q3
$18.5M Buy
220,695
+6,101
+3% +$481K 0.03% 419
2024
Q2
$16.5M Buy
214,594
+2,254
+1% +$165K 0.03% 456
2024
Q1
$14.5M Sell
212,340
-5,103
-2% -$328K 0.02% 506
2023
Q4
$12.6M Sell
217,443
-46,036
-17% -$2.46M 0.02% 529
2023
Q3
$13.9M Buy
263,479
+49,323
+23% +$2.59M 0.02% 481
2023
Q2
$11.6M Sell
214,156
-11,086
-5% -$579K 0.02% 538
2023
Q1
$11.3M Buy
225,242
+5,142
+2% +$242K 0.02% 550
2022
Q4
$10.2M Sell
220,100
-26,181
-11% -$1.13M 0.02% 560
2022
Q3
$9.54M Buy
246,281
+17,912
+8% +$719K 0.02% 570
2022
Q2
$8.51M Sell
228,369
-16,974
-7% -$691K 0.02% 624
2022
Q1
$10.9M Sell
245,343
-10,422
-4% -$452K 0.02% 611
2021
Q4
$10.9M Sell
255,765
-40,126
-14% -$1.69M 0.02% 616
2021
Q3
$12.8M Sell
295,891
-779,971
-72% -$34.5M 0.02% 552
2021
Q2
$46M Sell
1,075,862
-386,712
-26% -$16.3M 0.08% 255
2021
Q1
$56.5M Sell
1,462,574
-240,900
-14% -$9.12M 0.1% 215
2020
Q4
$61.2M Sell
1,703,474
-128,078
-7% -$4.62M 0.12% 184
2020
Q3
$70M Sell
1,831,552
-211,807
-10% -$8.16M 0.15% 150
2020
Q2
$71.7M Buy
2,043,359
+69,660
+4% +$2.51M 0.16% 146
2020
Q1
$64.4M Buy
1,973,699
+1,333,514
+208% +$52.1M 0.17% 136
2019
Q4
$28.9M Buy
640,185
+581,695
+995% +$24.3M 0.06% 322
2019
Q3
$2.38M Buy
58,490
+5,522
+10% +$234K 0.04% 325
2019
Q2
$2.28M Buy
52,968
+288
+0.5% +$11.1K 0.04% 331
2019
Q1
$2.02M Buy
52,680
+8,024
+18% +$306K 0.04% 348
2018
Q4
$1.58M Buy
44,656
+16,146
+57% +$586K 0.03% 371
2018
Q3
$1.1M Buy
28,510
+4,062
+17% +$142K 0.02% 465
2018
Q2
$800K Buy
24,448
+3,846
+19% +$116K 0.02% 512
2018
Q1
$563K Buy
20,602
+863
+4% +$23.5K 0.01% 556
2017
Q4
$490K Buy
19,739
+794
+4% +$21.9K 0.01% 591
2017
Q3
$552K Buy
18,945
+6,019
+47% +$166K 0.01% 559
2017
Q2
$359K Buy
12,926
+349
+3% +$9.26K 0.01% 630
2017
Q1
$313K Buy
12,577
+2,817
+29% +$68.5K 0.01% 680
2016
Q4
$212K Buy
+9,760
New +$213K ﹤0.01% 779

Other funds holding BSX